API, also known as Active Pharmaceutical Ingredients, are prepared by chemical synthesis, plant extraction, or biotechnology, but cannot be consumed directly by the patient.
| API | |
| Product Name | CAS No. |
| 1-Chloromethyl Naphathalene | 86-52-2 |
| 3,4-Dihydroxy-5-nitrobenzaldehyde | 116313-85-0 |
| 5-Nitro Vaniline | 6635-20-7 |
| 6-Methyl-2-(4-methyl phenyl)imidazo[1,2-a}pyridine-3-acetic acid | 189005-44-5 |
| Atrovastatin Calcium | 134523-03-8 |
| Enoxacin | 84294-96-2 |
| Ethambutol DiHcl | 1070-11-7 |
| Levetiracetam | 102767-28-2 |
| Lexofloxacin | 100986-85-4 |
| Metamizole Sodium | 5907-38-0 |
| N,N-Diethyl-2-yanoacetamide | 26391-06-0 |
| Norfloxacin | 70458-96-7 |
| Oxolinic Acid | 14698-29-4 |
| Rosuvastatin Calcium | 147098-20-2 |
| (S)-IndolIne-2 --carboxylic Acid | 79815-20-6 |
| API | |
| Product Name | CAS No. |
| 1-Chloromethyl Naphathalene | 86-52-2 |
| 3,4-Dihydroxy-5-nitrobenzaldehyde | 116313-85-0 |
| 5-Nitro Vaniline | 6635-20-7 |
| 6-Methyl-2-(4-methyl phenyl)imidazo[1,2-a}pyridine-3-acetic acid | 189005-44-5 |
| Atrovastatin Calcium | 134523-03-8 |
| Enoxacin | 84294-96-2 |
| Ethambutol DiHcl | 1070-11-7 |
| Levetiracetam | 102767-28-2 |
| Lexofloxacin | 100986-85-4 |
| Metamizole Sodium | 5907-38-0 |
| N,N-Diethyl-2-yanoacetamide | 26391-06-0 |
| Norfloxacin | 70458-96-7 |
| Oxolinic Acid | 14698-29-4 |
| Rosuvastatin Calcium | 147098-20-2 |
| (S)-IndolIne-2 --carboxylic Acid | 79815-20-6 |